Skip to main content

Table 4 Characteristics of the minimal CpG differential set for discrimination of the seven sarcoma clusters

From: Integrative DNA methylation and gene expression analysis in high-grade soft tissue sarcomas

Cluster comparison(a versus b)

Short name

CpG

Gene symbol

Area under curve (Mvalue) (%)

Hypermethylation (binary) (%)

Pairwise Wilcoxon test Pvalue

Kruskal–Wallis Pvalue

CpG region

 

Cluster a

Cluster b

  

1–2

4-02

cg10062065

SPEG

100

0

100

4.7 × 10–5

7.3 × 10–4

P

1–3

1-02

cg16907566

COL14A1

90

0

23

1.2E-03

9.6 × 10–5

P

1–4

3-30

cg00250430

DMRT2

85

0

61

2.3E-03

1.2 × 10–4

P

1–5

1-01

cg22298088

NNAT

100

0

100

1.8 × 10–5

1.1 × 10–5

P

1–6

5-01

cg00201234

FBLN2

100

67

0

4.2 × 10–5

1.1 × 10–4

P

1–7

2-01

cg08397758

PYROXD2

100

100

0

8.4 × 10–6

3.2 × 10–4

P

2–3

4-02

cg10062065

SPEG

100

100

0

6.3 × 10–5

7.3 × 10–4

P

2–4

4-06

cg00476577

ZNF217

99

0

89

2.7 × 10–5

1.9 × 10–4

P

2–5

4-02

cg10062065

SPEG

100

100

0

9.1 × 10–5

7.3 × 10–4

P

2–6

4-02

cg10062065

SPEG

100

100

0

1.4 × 10–4

7.3 × 10–4

P

2–7

2-01

cg08397758

PYROXD2

100

100

0

2.9 × 10–4

3.2 × 10–4

P

3–4

3-07

cg10895543

CDKN2A

91

29

91

4.7 × 10–5

2.8 × 10–6

GB

3–5

1-01

cg22298088

NNAT

100

0

100

3.0 × 10–5

1.1 × 10–5

P

3–6

5-01

cg00201234

FBLN2

100

67

0

8.3 × 10–5

1.1 × 10–4

P

3–7

2-01

cg08397758

PYROXD2

100

100

0

2.0 × 10–5

3.2 × 10–4

P

4–5

1-01

cg22298088

NNAT

100

0

82

5.0 × 10–6

1.1 × 10–5

P

4–6

5-01

cg00201234

FBLN2

99

67

0

2.7 × 10–5

1.1 × 10–4

P

4–7

2-01

cg08397758

PYROXD2

100

100

0

2.0 × 10–6

3.2 × 10–4

P

5–6

1-01

cg22298088

NNAT

100

0

100

7.6 × 10–5

1.1 × 10–5

P

5–7

2-01

cg08397758

PYROXD2

100

100

0

3.0 × 10–5

3.2 × 10–4

P

6–7

2-01

cg08397758

PYROXD2

100

100

0

4.2 × 10–5

3.2 × 10–4

P

  1. GB, gene body; P: promoter.